Why Is My Hair Thinning After Menopause?

Hair thinning becomes increasingly common during and after menopause. But that doesn't mean treatment options aren't available—or that every woman needs the same approach.

Maybe your part has gradually widened. Your ponytail feels thinner. Or you've noticed that your hair doesn't have the volume it once did.

For many women, these changes become more noticeable during perimenopause or after menopause.

Hormonal changes can play a role, but they're rarely the whole story.

And while hair loss is common with age, there are treatments that may help slow further thinning and, in some cases, improve hair growth.

Why does hair thinning become more common after menopause?

Hair growth is influenced by genetics, hormones, age, medical conditions, and other factors.

During menopause, estrogen levels decline. This hormonal transition may affect hair growth and can make underlying female-pattern hair loss more noticeable.

One of the most common causes of persistent thinning is female-pattern hair loss, also called androgenetic alopecia.

In this condition, susceptible hair follicles gradually produce thinner, shorter hairs. Over time, overall hair density decreases.

Despite its name, female-pattern hair loss isn't always driven by elevated androgen levels. Most affected women have normal circulating androgen levels, and the relationship between hormones and hair thinning is complex.

This helps explain why medications that block androgen activity can benefit some women but aren't consistently effective for everyone.

Unlike male-pattern hair loss, women often notice diffuse thinning over the top of the scalp or a progressively widening part rather than a receding hairline.

But not every change in hair density after menopause is female-pattern hair loss.

Thyroid disease, nutritional deficiencies, medication changes, inflammatory scalp conditions, and other causes can also contribute.

Is hair thinning after menopause normal, or is it female-pattern hair loss?

Some changes in hair texture, density, and growth can occur with aging. But progressive thinning shouldn't automatically be dismissed as a normal part of menopause.

Female-pattern hair loss often develops gradually. Common signs include:

  • A progressively widening part
  • Reduced density over the top or crown of the scalp
  • A thinner ponytail
  • Increasing visibility of the scalp through the hair

Other types of hair loss may look different.

Telogen effluvium, for example, often causes increased shedding across the scalp after an illness, significant stress, weight loss, or another trigger.

Inflammatory or scarring forms of alopecia may cause changes to the hairline, scalp symptoms, or more localized areas of hair loss.

These conditions can sometimes occur together, making the pattern of hair loss and accompanying symptoms important to assess.

How is hair thinning after menopause evaluated?

A medical evaluation starts with understanding how the hair loss developed.

Your physician may ask about the timing and pattern of thinning, recent illness or weight changes, medications, nutritional intake, and previous treatments.

Symptoms such as scalp itching, burning, eyebrow loss, or a changing frontal hairline can also provide important clues.

Depending on your history and examination, laboratory testing may include:

  • Thyroid-stimulating hormone (TSH) to evaluate thyroid function
  • Ferritin or iron studies to assess for iron deficiency
  • Vitamin D testing when deficiency is suspected or relevant risk factors are present
  • Androgen testing when symptoms suggest excess androgen activity, such as new facial hair growth, significant acne, or other signs of hormonal imbalance

Not every woman needs every test.

A clinician may also recommend an in-person scalp examination, dermoscopy or trichoscopy, or occasionally a scalp biopsy when the diagnosis is uncertain.

The goal is to distinguish ordinary pattern thinning from conditions that require a different approach.

Does hair grow back after menopause?

It depends on the cause.

Temporary shedding related to illness, stress, nutritional changes, or other triggers may improve when the underlying problem resolves.

Female-pattern hair loss, on the other hand, is generally progressive without treatment.

That doesn't mean treatment can't help.

Medications may slow further thinning, stabilize hair density, and sometimes produce meaningful regrowth.

For many women, maintaining the hair they have is an important treatment success, even when dramatic regrowth doesn't occur.

What are the best treatments for hair loss after menopause?

Treatment depends on the likely diagnosis, medical history, previous treatment response, and individual preferences.

Several medications may be considered, but the strength of evidence supporting them differs.

Topical and oral minoxidil for postmenopausal hair loss

Minoxidil is one of the most established treatments for female-pattern hair loss.

Topical minoxidil is FDA-approved in certain formulations for women and has substantial clinical evidence supporting its use. Low-dose oral minoxidil is also used off-label, supported by a growing body of research.

Both can promote hair growth, although the choice of formulation and dose depends on factors such as medical history, tolerance, and treatment preferences.

Some women experience a temporary increase in shedding when beginning minoxidil treatment. This can occur as hair follicles transition through their growth cycles and doesn't necessarily indicate treatment failure.

Topical minoxidil can cause scalp irritation or unwanted facial hair growth.

Oral minoxidil can also cause unwanted facial or body hair growth, fluid retention, dizziness, or cardiovascular side effects, so it isn't appropriate for everyone.

Spironolactone for female-pattern hair loss

Spironolactone is another medication sometimes used for female-pattern hair loss.

It has antiandrogen effects and may be useful for selected patients, including some women who have no other signs of elevated androgen activity.

However, the evidence supporting spironolactone for female-pattern hair loss is less robust than the evidence for minoxidil. Much of the available research comes from observational studies rather than large randomized controlled trials.

Because spironolactone can affect blood pressure and potassium levels, prescribing decisions depend on medical history, other medications, kidney function, and monitoring needs.

Its use for hair loss is off-label.

Finasteride and dutasteride after menopause

Finasteride and dutasteride reduce the production of dihydrotestosterone (DHT), a hormone involved in certain forms of pattern hair loss.

Both are familiar treatments in men's healthcare, but they may also be considered for selected postmenopausal women.

Neither medication is FDA-approved for treating hair loss in women.

The evidence for their effectiveness in women is more limited than it is for men, and not all studies have shown benefit.

For example, a randomized trial of finasteride 1 mg in postmenopausal women did not demonstrate meaningful improvement over placebo. Other studies using higher doses have reported benefits, but these findings are based largely on less rigorous evidence.

Research on dutasteride in women is also limited.

Potential side effects include breast tenderness, changes in sexual function, and mood symptoms. These medications also carry important reproductive precautions.

At Verilane Hair, finasteride and dutasteride are considered only for appropriately selected postmenopausal women.

Are there treatments other than medications?

Yes. Some women consider low-level light therapy devices, platelet-rich plasma (PRP) injections, or other procedures.

The evidence supporting these approaches varies, and treatment protocols aren't standardized across all providers.

They may be reasonable options for selected patients, particularly those who prefer to avoid medication or are interested in additional treatments.

A dermatologist who specializes in hair disorders can help determine whether these approaches are appropriate.

Why isn't there one standard treatment for every woman?

Because the same visible symptom—thinning hair—can have different causes.

A woman experiencing diffuse shedding after a major illness may need a very different approach from someone with gradually progressive thinning at the crown.

Even among women with female-pattern hair loss, treatment decisions may differ based on:

  • Age and reproductive stage
  • Cardiovascular and other medical conditions
  • Current medications
  • Previous hair-loss treatments and response
  • Side effects and treatment preferences
  • Whether laboratory testing or an in-person examination is needed

Some women do well with minoxidil alone. Others may benefit from a different dose, another medication, or combination treatment.

And some need further evaluation before prescription treatment is appropriate.

More treatment options are useful only when they're paired with individualized medical judgment.

How long does menopause hair loss treatment take to work?

Hair grows slowly.

Most treatments for pattern hair loss require several months before meaningful changes become visible.

Depending on the medication, it may take six to twelve months to adequately assess the response. Treatments such as spironolactone may require a particularly long trial before their benefit can be judged.

Taking photos in consistent lighting every few months can make subtle changes easier to recognize.

It's also important to understand that treatments for female-pattern hair loss generally need to be continued to maintain their benefits.

Stopping treatment may allow gradual thinning to resume.

When should you see a dermatologist for hair loss after menopause?

Not all hair loss can be safely evaluated or treated online.

An in-person examination is particularly important if you experience:

  • Sudden or rapidly progressive hair loss
  • Distinct bald patches
  • Scalp pain, burning, redness, or sores
  • Loss of eyebrows or eyelashes
  • Changes suggesting scarring or inflammation of the scalp
  • A progressively receding frontal hairline, particularly with eyebrow thinning

One condition that deserves particular attention is frontal fibrosing alopecia (FFA), a form of scarring hair loss that frequently affects postmenopausal women.

It can cause progressive recession of the frontal hairline, sometimes accompanied by eyebrow loss, scalp itching, burning, or redness.

Importantly, frontal fibrosing alopecia and female-pattern hair loss can occur together. Having a widening part or thinning crown doesn't rule out a separate condition affecting the frontal hairline.

Early recognition matters because scarring alopecia can permanently damage hair follicles.

An in-person dermatologist can examine the scalp and hairline closely, often using trichoscopy to look for signs of inflammation or scarring that may not be visible in ordinary photographs.

If your symptoms suggest one of these conditions, an in-person dermatology evaluation may be necessary.

Hair loss care designed with women in mind

At Verilane Hair, we recognize that women's hair loss doesn't always fit neatly into a standard treatment pathway.

Our physicians consider your reproductive stage, medical history, symptoms, previous treatments, and goals before recommending a plan.

Options may include oral minoxidil, spironolactone, finasteride, or dutasteride when clinically appropriate. We prescribe commercially available medications and send prescriptions to the pharmacy you choose.

You can complete your evaluation online, without scheduling an office appointment. When symptoms suggest a condition requiring closer examination, we'll recommend in-person care.

Your treatment shouldn't be predetermined.

Hair loss care, built around you.

Whether you're just beginning to notice thinning or have already tried treatment without satisfactory results, Verilane Hair offers individualized physician evaluation and a broader range of treatment options.

Start a Hair Visit — $44

All treatment decisions are based on physician review and clinical appropriateness. Some medications are prescribed off-label, and a specific treatment or prescription is not guaranteed. Some patients may require laboratory testing, an in-person examination, or specialty care.

Medical review: Lindsey McIlvena, MD, MPH

Last reviewed: October 2026

References

  1. Alenezi S, Ezzat RZ, Miteva M. Frontal Fibrosing Alopecia Part I – Diagnosis and Clinical Presentation. Journal of the American Academy of Dermatology. 2026.
  2. Kerkemeyer KLS, Eisman S, Bhoyrul B, Pinczewski J, Sinclair RD. Frontal Fibrosing Alopecia. Clinics in Dermatology. 2021.
  3. Olsen EA. Hair Loss in Women. The New England Journal of Medicine. 2025.
  4. Gupta AK, Economopoulos V, Mann A, Wang T, Mirmirani P. Menopause and Hair Loss in Women: Exploring the Hormonal Transition. Maturitas. 2025.
  5. Anderson A, Konopelski P, Skorzewska K, et al. The Role of Hormones in Female Androgenetic Alopecia: Focus on Menopause. Climacteric. 2026.
  6. Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. American Journal of Clinical Dermatology. 2026.
  7. van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for Female Pattern Hair Loss. Cochrane Database of Systematic Reviews. 2016.
  8. Female Pattern Hair Loss. The Handbook of Skin Disease Management. 2023.
  9. Wyche J, Senna M, Aguh C. Approach to Scarring Alopecia. JAMA Dermatology. 2025.
  10. Mirmirani P, Fu J. Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021. JAMA. 2021.
  11. Starace M, Orlando G, Alessandrini A, Piraccini BM. Female Androgenetic Alopecia: An Update on Diagnosis and Management. American Journal of Clinical Dermatology. 2020.